<!DOCTYPE html>

<html lang="en">
<head>
<script async="" src="https://www.googletagmanager.com/gtag/js?id=G-EPQ9202NVY"></script>
<script>
      window.dataLayer = window.dataLayer || [];
      function gtag(){dataLayer.push(arguments);}
      gtag('js', new Date());
      
      //- gtag('config', 'UA-71059016-1');
      gtag('config', 'G-EPQ9202NVY');
      
    </script>
<title>PDB-101: Molecule of the Month: Angiotensin and Blood Pressure</title>
<meta charset="utf-8"/>
<meta content="IE=edge" http-equiv="X-UA-Compatible"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<meta content="PDB101: Molecule of the Month: Angiotensin and Blood Pressure" property="og:title"/>
<meta content="Many medications for controlling high blood pressure inhibit the action of the peptide hormone angiotensin." property="og:description"/>
<meta content="https://cdn.rcsb.org/pdb101/motm/298/angiotensin_figure.jpg" property="og:image"/>
<meta content="http://pdb101.rcsb.org/motm/298" property="og:url"/>
<meta content="RCSB: PDB-101" property="og:site_name"/>
<meta content="summary" name="twitter:card"/>
<meta content="PDB101: Molecule of the Month: Angiotensin and Blood Pressure" name="twitter:title"/>
<meta content="Many medications for controlling high blood pressure inhibit the action of the peptide hormone angiotensin." name="twitter:description"/>
<meta content="https://cdn.rcsb.org/pdb101/motm/298/angiotensin_figure.jpg" name="twitter:image"/>
<meta content="Many medications for controlling high blood pressure inhibit the action of the peptide hormone angiotensin." name="description"/>
<meta content="Angiotensin,renin,ACE,angiotensin-converting enzyme,hypertension,high blood pressure,circulatory system,lisinopril,Aliskiren,blood,2x0b,1n9u,6os0,1o86,2v0z" name="keywords"/>
<!-- associate with our Google Analytics-->
<meta content="A8M31jAX8SUgQYzbnF5r-wgykna2i5Hp4J9fziVD9Sg" name="google-site-verification"/>
<link href="https://cdn.rcsb.org/pdb101/common/jquery-ui-1.11.4/jquery-ui.min.css" rel="stylesheet"/>
<link href="https://cdn.rcsb.org/javascript/bootstrap/latest/css/bootstrap.min.css" rel="stylesheet"/>
<link href="https://pdb101.rcsb.org/ekko-lightbox/ekko-lightbox.css" rel="stylesheet"/>
<link href="https://cdn.rcsb.org/javascript/fontawesome/fontawesome-free-6.7.2/css/all.min.css" rel="stylesheet"/>
<link href="https://cdn.rcsb.org/javascript/timeline3/css/timeline.css" rel="stylesheet"/>
<link href="https://pdb101.rcsb.org/css/style.css?v=20171201" rel="stylesheet"/>
<link href="https://cdn.rcsb.org/jira-feedback/css/jira-fdbck.css" rel="stylesheet"/><!--[if lt IE 9]>
    <script src="https://oss.maxcdn.com/html5shiv/3.7.2/html5shiv.min.js"></script>
    <script src="https://oss.maxcdn.com/respond/1.4.2/respond.min.js"></script><![endif]-->
<script src="https://cdn.rcsb.org/javascript/jquery/jquery-2.2.4.min.js"></script>
<script src="https://cdn.rcsb.org/pdb101/common/jquery-ui-1.11.4/jquery-ui.min.js"></script>
<script src="https://cdn.rcsb.org/javascript/bootstrap/latest/js/bootstrap.min.js"></script>
<script src="https://pdb101.rcsb.org/ekko-lightbox/ekko-lightbox.min.js"></script>
<script src="https://pdb101.rcsb.org/js/common.js"></script>
<script src="https://cdn.rcsb.org/jira-feedback/js/jira-fdbck.min.js"></script>
</head>
<body>
<div class="container" id="main_content">
<style>
          #jmolTabs {
              margin: 20px 0;
          }
          
          .motm-hr {
              color: #ccc;
              background-color: #ccc;
              height: 1px;
              border: none;
          }
          
          .jmolText {
              font-family: 'Helvetica Neue', Helvetica, Arial, sans-serif;
              font-size: 14px;
          }
          
          /* over-write bootstrap values */
          .nav-tabs {
              background: linear-gradient(to bottom, #fff, #ddd);
          }
          
          .tab-content {
              border-left: 1px solid #ddd;
              border-right: 1px solid #ddd;
              border-bottom: 1px solid #ddd;
              border-bottom-right-radius: 4px;
              border-bottom-left-radius: 4px;
              padding: 15px;
          }
          .nav-tabs > li.active > a, .nav-tabs > li.active > a:hover, .nav-tabs > li.active > a:focus {
              background-color: #fff;
              color: #333;
          }
          
          .tab-pane {
              padding-bottom: 10px;
          }
          
          #tabs-1 img {
              cursor: pointer;
          }
          
          .fa-cloud-download { margin-left:10px; }
          /* customize div.img-with-caption in style.css */
          div.img-with-caption {
              max-width: 50%;
              margin-top: 10px;
          }
          div.float-right { float: right; margin-left: 20px; }
          div.float-left { float: left; margin-right: 20px; }
          
          .link-motm {
              background-color: #d9ebd294;
              padding: 10px;
              border-radius: 4px;
              border: 1px solid #bcedbd;
              overflow-wrap: break-word;
          }
          div.jmol-image { margin-bottom: 5px; }
          
        </style>
<script>
          // jmol script
          var jmolLoaded = false
          function loadIframe() {
              if (jmolLoaded == false) {
                  var src = '/motm/jmol/?id=' + 298
                  console.log('src=' + src)
                  $("#iframe").attr('src', src)
                  jmolLoaded = true
              }
          }
          function clickJmolTab() {
              $('#jmol-tab').trigger('click')
          }
          
          // jmol script for legacy motms with multiple jmols
          var jmols = [];
          function loadIframeById(jmolId) {
              var jmol = jmols[jmolId - 1]
              if (jmol.loaded == false) {
                  var src = '/motm/jmol/?id=' + 298 + '&jmolId=' + jmolId
                  $("#iframe_" + jmolId).attr('src', src)
                  jmol.loaded = true
              }
          }
          function clickJmolTab(i) {
              var j = i + 1
              $('#jmol-tab-' + j).trigger('click')
          }
          
        </script>

<div data-elastic-include="">
<h1>Molecule of the Month: Angiotensin and Blood Pressure</h1>
<p><i>Many medications for controlling high blood pressure inhibit the action of the peptide hormone angiotensin.</i></p>
<div>
<div class="img-with-caption float-right">
<div class="img-with-caption-table"><img alt="Signaling pathway of angiotensin. The cell membrane is shown schematically in gray." class="img-responsive" src="https://cdn.rcsb.org/pdb101/motm/298/angiotensin_figure.jpg"/>
<div class="img-caption">
<div style="margin-bottom:10px;"><i>Signaling pathway of angiotensin. The cell membrane is shown schematically in gray.</i></div>
</div>
</div>
</div>
<div>Healthy blood pressure requires a delicate balance: the pressure needs to be high enough to circulate blood throughout the body, but not so high that it causes damage. Our bodies constantly monitor blood pressure and make changes if it gets out of the optimal range. The hormone angiotensin plays a central role in this control. It is released when blood pressure needs to be increased. It circulates through the body and has many effects, including constriction of blood vessels and making us feel thirsty.</div>
<h4>Sending Signals</h4>
<div>Angiotensin performs its job in several steps. It is made by liver cells as a large inactive precursor called angiotensinogen, which is released into the bloodstream when needed. The small protease renin is released concurrently from the kidneys and it trims angiotensinogen to a small decapeptide, called angiotensin I. Angiotensin I is then clipped by ACE (angiotensin-converting enzyme), removing two more amino acids to form the octapeptide angiotensin II. Angiotensin II is the active hormone, binding to receptors on cell surfaces throughout the body and launching many processes that control flow of water and salt, releasing additional hormones, and contracting blood vessels.</div>
<h4>Angiotensin in Action</h4>
<div>We can explore the molecular details of all of these molecules in the PDB archive. As seen in the interactive JSmol below, we can compare structures of the inactive precursor of renin (PDB ID <a href="https://www.rcsb.org/structure/3vcm" target="_blank">3vcm</a>) with the active form as it is clipping angiotensinogen (PDB ID <a href="https://www.rcsb.org/structure/2x0b" target="_blank">2x0b</a>). ACE is a membrane-bound enzyme with two similar protein-cutting domains that cleave angiotensin I as well as other peptide hormones. The full structure is shown here from a computed structure model (<a href="https://www.rcsb.org/structure/AF_AFP12821F1">AF_AFP12821F1</a>), and many experimental structures of the individual domains are available in the archive. Structures are also available for angiotensin I (PDB ID <a href="https://www.rcsb.org/structure/1n9u" target="_blank">1n9u</a>) and the receptor bound to angiotensin II (PDB ID <a href="https://www.rcsb.org/structure/6os0" target="_blank">6os0</a>).</div>
</div>
<div class="clearfix"></div>
<hr class="motm-hr"/>
<div>
<div class="img-with-caption float-left">
<div class="img-with-caption-table"><img alt="Complex of one ACE domain (blue) with the blood pressure drug lisinopril (yellow)." class="img-responsive" src="https://cdn.rcsb.org/pdb101/motm/298/1O86_MolStar.jpg"/>
<div class="img-caption">
<div style="margin-bottom:10px;"><i>Complex of one ACE domain (blue) with the blood pressure drug lisinopril (yellow).</i></div>
</div>
</div>
</div>
<h4>Blood Pressure Medication</h4>
<div>By understanding the structures of proteins involved in the angiotensin signaling pathway, researchers have developed drugs to modify their action and lower blood pressure, if needed. The widely-used drug lisinopril is shown here, bound in the active site of the angiotensin-cutting domain of ACE (PDB ID <a href="https://www.rcsb.org/structure/1o86" target="_blank">1o86</a>). Because blood pressure management is so important for health, other drugs have been developed to block the action of all the other steps of the signaling pathway. For example, the interactive JSMol below includes a drug that blocks the action of renin.</div>
</div>
<div class="clearfix"></div>
<hr class="motm-hr"/>
<h4>Exploring the Structure</h4>
<div class="jmolText" id="jmolTabs">
<ul class="nav nav-tabs">
<li class="active"><a data-toggle="tab" href="#tabs-1">Image</a></li>
<li><a data-toggle="tab" href="#tabs-2" id="jmol-tab" onclick="loadIframe();">JSmol</a></li>
</ul>
<div class="tab-content">
<div class="tab-pane active" id="tabs-1">
<h5>Renin in Action</h5>
<div class="img-with-caption float-left" style="margin-top:0;"><img class="img-responsive" onclick="clickJmolTab();" src="https://cdn.rcsb.org/pdb101/motm/298/Jmol-jmol.jpg"/></div>
<p>Three structures reveal different states of renin. PDB ID <a href="https://www.rcsb.org/structure/3vcm" target="_blank">3vcm</a> includes prorenin, the inactive form that is created inside kidney cells. After synthesis, the propeptide is clipped off and activated renin is stored safely in vesicles until itâ€™s needed. PDB ID <a href="https://www.rcsb.org/structure/2x0b" target="_blank">2x0b</a> shows how renin binds to angiotensinogen, positioning it perfectly so that it can cleave it in the proper place. PDB ID <a href="https://www.rcsb.org/structure/2v0z" target="_blank">2v0z</a> shows the drug Aliskiren bound in the active site, blocking the action of renin and helping to reduce blood pressure. <br/><br/> To explore these structures in more detail, click on the JSmol tab for an interactive view.</p>
<div class="clearfix"></div>
</div>
<div class="tab-pane" id="tabs-2">
<iframe frameborder="0" id="iframe" marginheight="0" marginwidth="0" scrolling="yes" width="100%"></iframe>
</div>
</div>
</div>
<div class="row">
<div class="col-xs-12 col-sm-12 col-md-6">
<h4>Topics for Further Discussion</h4>
<ol>
<li>The enzyme ACE2 is similar to the ACE described here. ACE2 makes additional cleavages in angiotensin and is used by SARS-CoV-2 as its receptor for infection. You can explore its structure in PDB ID <a href="https://www.rcsb.org/structure/6m17" target="_blank">6m17</a>.</li>
<li>You can use the Pairwise Structure Alignment tool to compare the two domains of ACE, using <a href="https://www.rcsb.org/alignment?request-body=eJydjssKwjAQRf9l1nHRgqV2J%2B71A6SU2ExrII%2BaTNFS8u9OKghu3U3mzD25KzxmDAs0K%2FiJtHcxjwFpDq6LyND12ClJEppBmohJQO8d4YvyofUKoYFJ6vDUEUGARbp7lZmTNjOyO2n06ICTkcLcsxr5l%2BsK6CgsneZrKC51xemIBvtcIwtkXOyHHhndcMyFtkUhOKu%2Bz319SEn8%2BMpTdf7bVxVlSi0rYdBm69qmNwBZZJU%3D&amp;response-body=eJzdlllPI0kSgP%2BLnw2qy3X0W8p5VCmjcvJSlVKtETJgGEtgeo09u6jFf59IQ7sNaqDFvK14ISvuiC9C%2Fj5Zra%2FuJl%2B%2BT3a71eXkyyRLm6siOU9OqoumPimuyvJkcXVRnVydl7P8vDlPr9LlZDq53y62u3vUn%2F%2FRa2CeTR6nk9vldhFdLW5W1%2Bvb5Xp7dnt3uUSlb4vV5r%2Br%2B2h4JFtu%2F7qLIbe3J%2Fuv0cVmeb%2B72aLjr98xxmZ3sd3hp%2F0TbTYPZ%2Fsk0z%2FqMiaxvFlebFd3633Q%2B4fbJylB0fny%2Bux%2B%2BZ%2F9h3SKtpeH56xuHh%2BnL%2Fxl81J92l%2BZZo%2BPf05%2Fpnt2qHGf92Z5jS5jDV%2Ff81o8PVfry%2BX%2FMEY2ndws19fbvyZfslkT833bNCtnL4yzqv5pnebF%2B9ZFkr%2BwLtLyyLpqsLZ3E0%2FzNzMvs%2FdDV%2BUL02p2FPgDy%2FqlZfXblnXy0rL5aTn7wDTNs5el5ulvh8UxvLLNj2yL%2FIMJxzQ%2FP%2BG0%2BmDCiO92s1jfX91tbhfbH7im0%2BT575f%2FIRcnyWmTpFWZNumsmianWZ4nWVI3TT5FUV4WSZGlVV2iOr5TVMpnZZ7P4qvBNGZ5WWXZXjctk1kzy6riSReFxSxJs6aMr6zI6qqqmiwGqTFeWmZFUscsTpMatdK8qfNpWkRhk6VZUdfTMj1F%2F02eNLNZhunGHd3d3i42D3G%2F7y%2FuflyWvxc3OzxTyekMAdw%2BfIsnC3u3W64vlierS1zk1fZhEnt80Gyag6bvT%2Fa%2BXinUBwXbOzqJF2KNl2F9hlFXl7vlWTyKGH9WZVESL%2BXN8vKHNCY2w17gcYlp4yCjKc5sf2%2FiGV2fXdz9vdwsrjHE1zRJpk3%2B59Mdes78zTP0uSv00S6Xn97lsvrsLpf153c5bT6%2Fy1ny9i7jqv7rezu5Xnx7mtSRXnKktZ%2FFceXFq%2BSPZeU7svptWZon7wmzt4XFMTfFKyEu%2BXG5x8Ris2DwlBFGnOQDY4Fa78wwjIoF%2FKhGFZRXnffMO9kBGKl60xHVepBBeEOs5HRQBozyvpO266QcDAVmCQFNDAP0qaIl7Zn3wQ3ED%2FNWK%2BHmYIBpCl4NPfHOysAowEhGJkZLJRGWdGB40DIMDDplCLGgRBgoEdSN1vWBee2A7cMBx1hGQwAFLQmDtQRa2wZBTNspYEJ3mrQAQvUjMX50qgsUhkFz7Yh2PcUSSQ%2FSiNFra3suGaGUc%2B9AAOhBa8ZHJV0PTGpPhWUD1kEcGSkPSkjKbSfN3PsBg0XHpG1ZL9rOBN6bICn6IGCZIEoL3jLSCToAATc4r2ULrcPEwTkmhKOspZ3i0MueAJUd4Z3mLsBAzWhHO3AqXOclw9kYNo4OLA7DCJhrzNN6IyinWhDJ2047N%2BjQ2cAHx7vOcBNjwxybKVovNLRyTrtgHJYrjAXiSS9BcGf1qLEhBjovjFa9w1J7cIFLjbMcwXqmGLSCofaoTVDYNuX2F%2Fn37l46fWPV4q%2B7V4hiNThbobgjyCqOFDgxLijnCDMDjh6xIm4kLY2sEqaItYYxRBCcYRxBHoWRRDIITHejUdxTbcAiroIM1oNwRIEGIq3BUqIZVmy74DyRwxy0kp74OXaa7oHtgDhnXcCOYCYR2FZhQzsN2B3EmHscrGIkSEMFxvKCBAR2xIy154wisC0EE%2Fl%2FBpY%2FA2uDoDYgsPYALI3AupFFYPs9sFRqBXTwzvdgEFhFfNtzOxDG9sAycLrfA8vEE7DkNbD2AKwdfE8NOD8cgA3wDCySZX8JLKbfyg4Xg6K5op45BDYARGBZBBY0Fz%2BAFQN3wnqtnQ2K03EMSE8EtovAequYbzkudQR20GrwB2AHOAAb%2BQwsAmsisNZ5GS3ASlQiwkVgDRtAYo8EUNwbgtcA94IbjGFGMMwoY5RAHQSWBTO2WoOmKmgmuqefC%2F%2F%2FP1Ye%2FwERg3Cn&amp;encoded=true"> PDB ID 1o86 and 2c6n.</a></li>
</ol>
<div data-elastic-exclude="">
<div class="col-xs-12 link-motm">
<h4>Related PDB-101 Resources</h4>
<ul>
<li>Browse <a href="https://pdb101.rcsb.org/browse/cellular-signaling">Cellular Signaling</a></li>
<li>Browse <a href="https://pdb101.rcsb.org/browse/peak-performance">Peak Performance</a></li>
<li>Browse <a href="https://pdb101.rcsb.org/browse/you-and-your-health">You and Your Health</a></li>
</ul>
</div>
</div>
</div>
<div class="col-xs-12 col-sm-12 col-md-6" style="border-left:1px dashed #ddd;">
<h4>References</h4>
<ol>
<li>Fountain, J. H., Kaur, J., Lappin, S. L. (2024) Physiology, Renin Angiotensin System. StatPearls <a href="https://www.ncbi.nlm.nih.gov/books/NBK470410/">www.ncbi.nlm.nih.gov/books/NBK470410/</a></li>
<li>6os0: Wingler, L.M., Skiba, M.A., McMahon, C., Staus, D.P., Kleinhenz, A.L.W., Suomivuori, C.M., Latorraca, N.R., Dror, R.O., Lefkowitz, R.J., Kruse, A.C. (2020) Angiotensin and biased analogs induce structurally distinct active conformations within a GPCR. Science 367: 888-892</li>
<li>Bernstein, K.E., Ong, F.S., Blackwell, W.L.B., Shah, K.H., Giani, J.F., Gonzalez-Villalobos, R.A., Shen, X.Z., Fuchs, S. (2013) A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme. Pharmacol Rev 65: 1-46</li>
<li>2x0b: Zhou, A., Carrell, R.W., Murphy, M.P., Wei, Z., Yan, Y., Stanley, P.L., Stein, P.E., Pipkin, F.B., Read, R.J.(2010) A redox switch in angiotensinogen modulates angiotensin release. Nature 468: 108</li>
<li>1o86: Natesh, R., Schwager, S.L.U., Sturrock, E.D., Acharya, K.R. (2003) Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 421: 551</li>
<li>1n9u: Spyroulias, G.A., Nikolakopoulou, P., Tzakos, A., Gerothanassis, I.P., Magafa, V., Manessi-Zoupa, E., Cordopatis, P. (2003) Comparison of the solution structures of angiotensin I &amp; II. Implication for structure-function relationship. Eur J Biochem 270: 2163-2173</li>
<li>2v0z: Rahuel, J., Rasetti, V., Maibaum, J., Rueger, H., Goschke, R., Cohen, N.C., Stutz, S., Cumin, F., Fuhrer, W., Wood, J.M., Grutter, M.G. (2000) Structure-based drug design: The discovery of novel nonpeptide orally active inhibitors of human renin. Chem Biol 7: 493-504</li>
</ol>
</div>
</div>
<hr class="motm-hr"/>
<p>October 2024, David Goodsell</p> <a href="http://doi.org/10.2210/rcsb_pdb/mom_2024_10">http://doi.org/10.2210/rcsb_pdb/mom_2024_10</a>
</div>
<div class="row hidden-print" style="margin-top:20px;">
<div class="col-xs-12">
<div class="panel panel-info">
<div class="panel-heading">About Molecule of the Month</div>
<div class="panel-body"><small>
                   
                  The RCSB PDB Molecule of the Month by David S. Goodsell (The Scripps Research Institute and the RCSB PDB) presents short accounts on selected molecules from the Protein Data Bank. Each installment includes an introduction to the structure and function of the molecule, a discussion of the relevance of the molecule to human health and welfare, and suggestions for how visitors might view these structures and access further details.<a href="https://pdb101.rcsb.org/motm/motm-about">More</a></small>
</div>
</div>
</div>
</div>
<script>
          $('#iframe').load(function () {
              $(this).height($(this).contents().find('body').height() + 30);
          });
        </script>
</div>
</body>
</html>
